Kishor Mayekar

Array ( [id] => 4361533 [patent_doc_number] => 06169177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Processes for the synthesis of oligomeric compounds' [patent_app_type] => 1 [patent_app_number] => 9/187995 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7482 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169177.pdf [firstpage_image] =>[orig_patent_app_number] => 187995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209881 [patent_doc_number] => 06028181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => '6-0-Substituted antibacterial erythromycin ketolides and methods of making' [patent_app_type] => 1 [patent_app_number] => 9/186395 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61146 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1863 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028181.pdf [firstpage_image] =>[orig_patent_app_number] => 186395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129827 [patent_doc_number] => 06127535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Nucleoside triphosphates and their incorporation into oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/186675 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7526 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127535.pdf [firstpage_image] =>[orig_patent_app_number] => 186675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134842 [patent_doc_number] => 06147197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => '6-O-substituted erythromycin ketolides having antibacterial activity' [patent_app_type] => 1 [patent_app_number] => 9/185903 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61378 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147197.pdf [firstpage_image] =>[orig_patent_app_number] => 185903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237039 [patent_doc_number] => 06075133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => '6-O-substituted antibacterial erythromycin ketolides and methods of making' [patent_app_type] => 1 [patent_app_number] => 9/185883 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61568 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 1534 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075133.pdf [firstpage_image] =>[orig_patent_app_number] => 185883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360571 [patent_doc_number] => 06175001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Functionalized pyrimidine nucleosides and nucleotides and DNA\'s incorporating same' [patent_app_type] => 1 [patent_app_number] => 9/173672 [patent_app_country] => US [patent_app_date] => 1998-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 8769 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/175/06175001.pdf [firstpage_image] =>[orig_patent_app_number] => 173672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4073735 [patent_doc_number] => 06069243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Process for oligonucleotide synthesis' [patent_app_type] => 1 [patent_app_number] => 9/167165 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7507 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069243.pdf [firstpage_image] =>[orig_patent_app_number] => 167165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949565 [patent_doc_number] => 05998608 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Method of manufacturing an aldose or an aldose derivative' [patent_app_type] => 1 [patent_app_number] => 9/166956 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2664 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998608.pdf [firstpage_image] =>[orig_patent_app_number] => 166956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185120 [patent_doc_number] => 06020483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Nucleoside modifications by palladium catalyzed methods' [patent_app_type] => 1 [patent_app_number] => 9/160747 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5652 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020483.pdf [firstpage_image] =>[orig_patent_app_number] => 160747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1141025 [patent_doc_number] => 06777210 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1' [patent_app_type] => B1 [patent_app_number] => 09/160284 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8131 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777210.pdf [firstpage_image] =>[orig_patent_app_number] => 09160284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379113 [patent_doc_number] => 06277570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents' [patent_app_type] => 1 [patent_app_number] => 9/149161 [patent_app_country] => US [patent_app_date] => 1998-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 15341 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277570.pdf [firstpage_image] =>[orig_patent_app_number] => 149161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4222184 [patent_doc_number] => 06040439 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Method for chemical synthesis of oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/145973 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2002 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040439.pdf [firstpage_image] =>[orig_patent_app_number] => 145973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409564 [patent_doc_number] => 06172209 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Aminooxy-modified oligonucleotides and methods for making same' [patent_app_type] => 1 [patent_app_number] => 9/130973 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 33500 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172209.pdf [firstpage_image] =>[orig_patent_app_number] => 130973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4219618 [patent_doc_number] => 06087499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Process for producing 5-perfluoroalkyluracil derivatives' [patent_app_type] => 1 [patent_app_number] => 9/129344 [patent_app_country] => US [patent_app_date] => 1998-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5664 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087499.pdf [firstpage_image] =>[orig_patent_app_number] => 129344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143046 [patent_doc_number] => 06060597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases' [patent_app_type] => 1 [patent_app_number] => 9/127126 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5212 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060597.pdf [firstpage_image] =>[orig_patent_app_number] => 127126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105928 [patent_doc_number] => 06051701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Sulfated hyaluronic acid esters' [patent_app_type] => 1 [patent_app_number] => 9/126135 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7990 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051701.pdf [firstpage_image] =>[orig_patent_app_number] => 126135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450381 [patent_doc_number] => 06455506 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Lyxofuranosyl benzimidazoles as antiviral agents' [patent_app_type] => B1 [patent_app_number] => 09/124484 [patent_app_country] => US [patent_app_date] => 1998-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18169 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455506.pdf [firstpage_image] =>[orig_patent_app_number] => 09124484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239608 [patent_doc_number] => 06143879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Nucleotide cleaving agents and method' [patent_app_type] => 1 [patent_app_number] => 9/123848 [patent_app_country] => US [patent_app_date] => 1998-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10206 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143879.pdf [firstpage_image] =>[orig_patent_app_number] => 123848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408145 [patent_doc_number] => 06271358 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'RNA targeted 2\'-modified oligonucleotides that are conformationally preorganized' [patent_app_type] => 1 [patent_app_number] => 9/123108 [patent_app_country] => US [patent_app_date] => 1998-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13341 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271358.pdf [firstpage_image] =>[orig_patent_app_number] => 123108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194750 [patent_doc_number] => 06043354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Method for the simultaneous isolation of genomic DNA and high-purity RNA' [patent_app_type] => 1 [patent_app_number] => 9/101935 [patent_app_country] => US [patent_app_date] => 1998-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3025 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043354.pdf [firstpage_image] =>[orig_patent_app_number] => 101935 [rel_patent_id] =>[rel_patent_doc_number] =>)